These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3088024)

  • 1. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement.
    Dawson-Hughes B; Stern D; Goldman J; Reichlin S
    J Clin Endocrinol Metab; 1986 Aug; 63(2):424-32. PubMed ID: 3088024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.
    Pavlov EP; Harman SM; Merriam GR; Gelato MC; Blackman MR
    J Clin Endocrinol Metab; 1986 Mar; 62(3):595-600. PubMed ID: 3080468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons.
    Copeland KC; Johnson DM; Kuehl TJ; Castracane VD
    J Clin Endocrinol Metab; 1984 Apr; 58(4):698-703. PubMed ID: 6199364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) response to GH-releasing hormone in depression.
    Lesch KP; Laux G; Pfüller H; Erb A; Beckmann H
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1278-81. PubMed ID: 3119657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
    Copeland KC
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
    Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
    J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.